Skip to main content

Table 3 Characteristics of the control patients and cardiac and plasma levels of succinate

From: Succinate causes pathological cardiomyocyte hypertrophy through GPR91 activation

Study characteristics
Number patients, n 15
Control 6
Cardiac 9
Median age, years 62 ± 2.7*
Pathological condition Number of patients
Coronary artery disease, n 5
Acute myocardial infarction, n 3
Coronary artery disease + Acute myocardial infarction, n 1
Total 9
Median blood levels NT-pro-BNP (pg/mL)  
Coronary artery disease 8101 ± 4524*
Acute myocardial infarction 171 ± 101*
Coronary artery disease + Acute myocardial infarction 25000
Median blood levels succinate (mmol/L)  
Coronary artery disease 0.9 ± 0.1*
Acute myocardial infarction 1 ± 0.2*
Coronary artery disease + Acute myocardial infarction 2.69
  1. *The results are expressed as mean ± S.E.M.